Scrutiny of SAS-B data for psychiatric conditions exposes prescribing ‘disconnect’ by Steve Jones June 7, 2023April 30, 2024 Patients are being prescribed medicinal cannabis for psychiatric conditions where evidence is lacking or unclear, in […]
Gender bias and medicinal cannabis research: where do we go from here? by Hannah Adler June 16, 2022April 29, 2024
Flower prescriptions for anxiety growing despite lack of evidence, according to new Lambert study by Martin Lane May 10, 2022April 29, 2024
Australian Rheumatology Association calls for more evidence on cannabis by Hannah Adler December 15, 2021April 29, 2024